| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.1M | +7.2% | -16.1% |
| Cost of Revenue | $9.2M | -2.0% | -18.8% |
| Gross Profit | $4.9M | +30.0% | -10.4% |
| R&D Expense | $536K | -48.3% | -44.0% |
| SG&A Expense | $3.6M | -27.4% | -40.5% |
| Operating Income | $795K | +136.5% | +153.8% |
| Net Income | $601K | +123.5% | +131.8% |
| EPS (Basic) | $0.03 | +120.0% | +127.3% |
| EPS (Diluted) | $0.03 | +120.0% | +127.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $8.5M | +13.5% | +0.5% |
| Inventory | $15.7M | -0.1% | +2.5% |
| Current Assets | $27.6M | +2.5% | +8.3% |
| Total Assets | $30.1M | +1.4% | +4.0% |
| Current Liabilities | $22.1M | -31.2% | -28.0% |
| Total Liabilities | $22.6M | -31.6% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | -580.8% | — |
| Capital Expenditures | $285K | +74.8% | — |
| Investing Cash Flow | -$285K | -74.8% | — |
| Financing Cash Flow | $4.2M | +979.9% | — |
| Free Cash Flow | -$4.6M | -728.0% | — |
| -28.8% |
| Stockholders' Equity | $7.5M | +327.0% | +375.3% |